Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-Arm Study of the Efficacy of EsoGuard(TM) on Samples Collected Using EsoCheck(TM) Versus Esophagogastroduodenoscopy for the Diagnosis of Barrett's Esophagus in an At-Risk Screening Population

NCT04293458 is registered in ClinicalTrials.gov with Lucid Diagnostics, Inc. as lead sponsor.

NCT NCT04293458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04293458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-Arm Study of the Efficacy of EsoGuard(TM) on Samples Collected Using EsoCheck(TM) Versus Esophagogastroduodenoscopy for the Diagnosis of Barrett's Esophagus in an At-Risk Screening Population
Lead sponsor
Lucid Diagnostics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2020
Completion date
August 22, 2022
Enrollment
145 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, barrett's esophagus without dysplasia, barretts esophagus with dysplasia, esophageal adenocarcinoma